FIBROGEN INC Intellectual Property Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to the Exclusive License and Option Agreement, between FibroGen, Inc. and HiFiBiO Inc., dated February 14, 2024
License Agreements
FIBROGEN INC
Biotechnology
2024
Amendment No. 1 to the Second Amended and Restated Exclusive License Agreement, dated as of November 16, 2023
License Agreements
FIBROGEN INC
Biotechnology
2024
Amended and Restated Exclusive License Agreement by and among FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd., and Eluminex Biosciences Suzhou) Limited,...
License Agreements
FIBROGEN INC
Biotechnology
NY
2023
Amended and Restated Exclusive License Agreement by and between FibroGen, Inc. and Eluminex Biosciences (Suzhou) Limited as of January 21, 2022
License Agreements
FIBROGEN INC
Biotechnology
NY
2022
Exclusive License Agreement by and between FibroGen, Inc. and Eluminex Biosciences (Suzhou) Limited as of July 16, 2021
License Agreements
FIBROGEN INC
Biotechnology
NY
2021
Exclusive License and Option Agreement by and between FibroGen, Inc. and HiFiBiO (HK) Limited (D.B.A. HiFiBiO Therapeutics), as of June 16, 2021
License Agreements
FIBROGEN INC
Biotechnology
IL
2021
Amendment No. 1 to the Amended and Restated License, Development and Commercialization Agreement by and between FibroGen, Inc. and AstraZeneca AB, effective as of July 1, 2020
License Agreements
FIBROGEN INC
Biotechnology
2020
Second Amended and Restated License, Development and Commercialization Agreement by and among FibroGen China Anemia Holdings, Ltd., FibroGen China Medical Technology Development...
License Agreements
FIBROGEN INC
Biotechnology
CA
2020
AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (for the US and Certain Other Territories) between FIBROGEN, INC. and ASTRAZENECA AB
License Agreements
FIBROGEN INC
Biotechnology
CA
2014
AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (CHINA) between FIBROGEN CHINA ANEMIA HOLDINGS, LTD.; BEIJING FIBROGEN MEDICAL TECHNOLOGY DEVELOPMENT...
License Agreements
FIBROGEN INC
Biotechnology
CA
2014
AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (for the US and Certain Other Territories) between FIBROGEN, INC. and ASTRAZENECA AB
License Agreements
FIBROGEN INC
Biotechnology
CA
2014